ChemicalBook >> CAS DataBase List >>Paricalcitol

Paricalcitol

CAS No.
131918-61-1
Chemical Name:
Paricalcitol
Synonyms
Zemplar;CS-1390;Zemplarr;PARICALCITOL;Paricalciferol;D6-Paricalcitol;Paricalcitol, >=98%;Paricalcitol(Zemplar);19-Nor-1,25- dihydroxyvitaMin D2;1α,25-Dihydroxy-19-nor-vitaMin D2
CBNumber:
CB0500520
Molecular Formula:
C27H44O3
Molecular Weight:
416.65
MDL Number:
MOL File:
131918-61-1.mol
MSDS File:
SDS
Last updated:2026-03-13 23:13:44
Product description Number Pack Size Price
Paricalcitol 1499414 3ml $924
Paricalcitol 1499403 10mg $3910
Paricalcitol ≥98% 17716 500μg $98
Paricalcitol ≥98% 17716 1mg $186
Paricalcitol ≥98% 17716 5mg $778
More product size

Paricalcitol Properties

Boiling point 564.8±50.0 °C(Predicted)
Density 1.121±0.06 g/cm3(Predicted)
Flash point 14℃
storage temp. Store at -20°C,unstable in solution, ready to use.
solubility DMSO : 100 mg/mL (240.02 mM; Need ultrasonic)Ethanol : 12.5 mg/mL (30.00 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
form Solid
pka 14.34±0.40(Predicted)
color White to off-white
InChIKey BPKAHTKRCLCHEA-UBFJEZKGSA-N
SMILES C[C@]12CCC/C(=C\C=C3C[C@@H](O)C[C@H](O)C3)/[C@]1([H])CC[C@]2([H])[C@H](C)/C=C/[C@H](C)C(O)(C)C |&1:1,10,13,16,20,22,26,r|
CAS DataBase Reference 131918-61-1(CAS DataBase Reference)
FDA UNII 6702D36OG5
NCI Dictionary of Cancer Terms paricalcitol
NCI Drug Dictionary paricalcitol
ATC code H05BX02
UNSPSC Code 41116107
NACRES NA.77

Pharmacokinetic data

Protein binding >99%
Excreted unchanged in urine 0 (16% as metabolites)
Volume of distribution 17-25 Litres (6 Litres in haemodialysis patients)
Biological half-life 15 (oral 5-7) / Unchanged

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictogramsGHS hazard pictograms
GHS06,GHS08
Signal word  Danger
Hazard statements  H301+H311-H330-H372
Precautionary statements  P280-P301+P310+P330-P302+P352+P312-P304+P340+P310-P314
RIDADR  UN1170 - class 3 - PG 2 - Ethanol, solution
WGK Germany  WGK 3
HS Code  2936299055
Storage Class 6.1A - Combustible acute toxic Cat. 1 and 2
very toxic hazardous materials
Hazard Classifications Acute Tox. 2 Inhalation
Acute Tox. 3 Dermal
Acute Tox. 3 Oral
STOT RE 1 Oral
Hazardous Substances Data 131918-61-1(Hazardous Substances Data)
NFPA 704
0
4 0

Paricalcitol price More Price(27)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich 1499414 Paricalcitol 131918-61-1 3ml $924 2025-07-31 Buy
Sigma-Aldrich 1499403 Paricalcitol 131918-61-1 10mg $3910 2025-07-31 Buy
Cayman Chemical 17716 Paricalcitol ≥98% 131918-61-1 500μg $98 2024-03-01 Buy
Cayman Chemical 17716 Paricalcitol ≥98% 131918-61-1 1mg $186 2024-03-01 Buy
Cayman Chemical 17716 Paricalcitol ≥98% 131918-61-1 5mg $778 2024-03-01 Buy
Product number Packaging Price Buy
1499414 3ml $924 Buy
1499403 10mg $3910 Buy
17716 500μg $98 Buy
17716 1mg $186 Buy
17716 5mg $778 Buy

Paricalcitol Chemical Properties,Uses,Production

Description

Paricalcitol was launched as Zemplar in the US for the prevention and treatment of secondary hyperthyroidism associated with chronic renal failure. Paricalcitol is a synthetic vitamin D2, namely a novel 1-alpha-hydroxy-19-noranalogue in which the ring A exocyclic methylene group, typical of all vitamin D systems, has been replaced by two hydrogen atoms. Paricalcitol is the first vitamin D analogue marketed for this indication. In patients with chronic renal failure, Paricalcitol appreciably reduced levels of parathyroid hormone (PTH) without a significant difference in the incidence rate for hypercalcemia or hyperphosphatemia when compared with placebo.

Description

Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.

Chemical Properties

White Solid

Originator

Abbott (US)

Uses

Antihyperparathyriod

Uses

1,25-Dihydroxy vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have applications in those contexts as well.

Uses

Synthetic analog of vitamin D. Antihyperparathyroid.

Definition

ChEBI: Paricalcitol is a seco-cholestane and a hydroxy seco-steroid. It has a role as an antiparathyroid drug. It is functionally related to a vitamin D2.

brand name

Zemplar (Abbott).

Clinical Use

Vitamin D analogue:
Treatment and prevention of secondary hyperparathyroidism associated with chronic renal failure

Metabolism

Extensively metabolised via hepatic and non-hepatic pathways to form two relatively inactive metabolites. After oral administration of 3 H-paricalcitol, only about 2% of the dose was eliminated unchanged in the faeces, and no parent drug found in the urine.
Approximately 70% of the radioactivity was eliminated in the faeces and 18% was recovered in the urine. Most of the systemic exposure was from the parent drug.

References

[1] ALEX J BROWN. Calcemic activity of 19-Nor-1,25(OH)(2)D(2) decreases with duration of treatment.[J]. Journal of The American Society of Nephrology, 2000, 11 11: 2088-2094. DOI: 10.1681/asn.v11112088
[2] JAVIER DONATE-CORREA. Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease.[J]. Current drug targets, 2014, 15 7: 703-709. DOI: 10.2174/1389450115666140417120902
[3] MYLES WOLF  Ravi T. Vitamin D in patients with renal failure: A summary of observational mortality studies and steps moving forward[J]. Journal of Steroid Biochemistry and Molecular Biology, 2007, 103 3: Pages 487-490. DOI: 10.1016/j.jsbmb.2006.11.009
[4] DARKO DUPLANCIC. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.[J]. Clinical Interventions in Aging, 2013, 8: 149-156. DOI: 10.2147/cia.s38349

Paricalcitol Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 293)Suppliers
Supplier Tel Email Country ProdList Advantage
airuikechemical co., ltd.
+86-18353166132 sales02@airuikechemical.com China 983 58
HangZhou RunYan Pharma Technology Co.,LTD.
+8618882027439 sales2@runyanpharma.com China 302 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718; +8613336195806 sales@capot.com China 29735 60
Shanghai Daken Advanced Materials Co.,Ltd
+86-2158073036 info@dakenam.com China 13822 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21595 55
Shanghai Zheyan Biotech Co., Ltd.
18017610038 zheyansh@163.com CHINA 3619 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 965 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19552 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49977 58
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29795 58

View Lastest Price from Paricalcitol manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Paricalcitol pictures 2026-03-13 Paricalcitol
131918-61-1
US $147.00-745.00 / mg 99.84% 10g TargetMol Chemicals Inc.
Paricalcitol pictures 2025-08-21 Paricalcitol
131918-61-1
US $0.00-0.00 / g 1g 99.0%min. HPLC 10000 HangZhou RunYan Pharma Technology Co.,LTD.
Paricalcitol pictures 2024-12-24 Paricalcitol
131918-61-1
US $0.00-0.00 / Kg 1Kg 99.9% 20tons airuikechemical co., ltd.
  • Paricalcitol pictures
  • Paricalcitol
    131918-61-1
  • US $147.00-745.00 / mg
  • 99.84%
  • TargetMol Chemicals Inc.
  • Paricalcitol pictures
  • Paricalcitol
    131918-61-1
  • US $0.00-0.00 / g
  • 99.0%min. HPLC
  • HangZhou RunYan Pharma Technology Co.,LTD.
  • Paricalcitol pictures
  • Paricalcitol
    131918-61-1
  • US $0.00-0.00 / Kg
  • 99.9%
  • airuikechemical co., ltd.

Paricalcitol Spectrum

CS-1390 PARICALCITOL (10 MG)F0E3030.997MG/MG(AI) PARICALCITOL 19-nor-1alpha,25-dihydroxyvitamin D2 (1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]cyclohexane-1,3-diol Zemplar 1,3-Cyclohexanediol, 5-[(2E)-2-[(1R,3aS,7aR)-octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethyl-2-hexen-1-yl]-7a-methyl-4H-inden-4-ylidene]ethylidene]-, (1R,3R,5Z)- Paricalcitol, >=98% 1,25-DihydroxyvitaMin D2 Paricalcitol Paricalcitol(Zemplar) Paricalcitol (10 mg) (COLD SHIPMENT REQUIRED) (1R,3R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-Octahydro-1-[(1R,2E,4S)-5-hydroxy-1,4,5-triMethyl-2-hexen-1-yl]-7a-Methyl-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol (1α,3β,7E,22E)-19-Nor-9,10-secoergosta-5,7,22-triene-1,3,25-triol 19-Nor-1,25- dihydroxyvitaMin D2 1α,25-Dihydroxy-19-nor-vitaMin D2 Paricalcitol/ 19-nor-1α,25-dihydroxyergocalciferol (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol ParicalcitolQ: What is Paricalcitol Q: What is the CAS Number of Paricalcitol Q: What is the storage condition of Paricalcitol Q: What are the applications of Paricalcitol Paricalcitol (COLD SHIPMENT REQUIRED) (1499403) (1R,3R)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)cyclohexane-1,3-diol Paricalciferol Zemplarr (1R,3R)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol D6-Paricalcitol 131918-61-1 131919-61-1 Vitamin D3 analogs Chiral Reagents Intermediates & Fine Chemicals Pharmaceuticals 131918-61-1